Milestones in clinical pharmacology. Therapy for hypertension

HEMOGLOBIN REGENERATION IN THE CHRONIC HEMORRHAGIC ANEMIA OF DOGS (WHIPPLE) : I. THE EFFECT OF IRON AND PROTEIN FEEDING.

The Journal of experimental medicine·2009

Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists.

Psychoneuroendocrinology·1995

Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.

Brain, behavior, and immunity·1994

Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion.

Psychoneuroendocrinology·1994

Central 5-HT1A receptors inhibit adrenocortical secretion.

Neuroendocrinology·1993

Effects of intracerebroventricular and intrahypothalamic cocaine administration on adrenocortical secretion.

Neuroendocrinology·1993

The Endocannabinoid System is No Longer the Limiting Factor: Why Policy and Stigma Continue to Delay Cannabinoid-Based Medicine.

Clinical therapeutics·2026

Physiologically Based Pharmacokinetic Modeling of Lenvatinib to Support Dosing Optimization in Chinese Population.

Clinical therapeutics·2026

Effects of Phosphodiesterase-5 Inhibitors on Mortality and Clinical Outcomes in Advanced Interstitial Lung Disease with Severe Impairment in Gas Exchange: A Systematic Review and Meta-Analysis.

Clinical therapeutics·2026

Early Hemodynamic Trajectory Phenotypes and Exploratory Albumin Exposure-Mortality Associations in Septic Shock: A Retrospective Cohort Study.

Clinical therapeutics·2026

Issues in Monitoring Oncology Trials.

Clinical therapeutics·2026

Benefit-Risk Balance for Medicinal Products: Report Summary from the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII.

Clinical therapeutics·2026

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Related Experiment Videos

Milestones in clinical pharmacology. Therapy for hypertension

Related Concept Videos

HEMOGLOBIN REGENERATION IN THE CHRONIC HEMORRHAGIC ANEMIA OF DOGS (WHIPPLE) : I. THE EFFECT OF IRON AND PROTEIN FEEDING.

Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists.

Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.

Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion.

Central 5-HT1A receptors inhibit adrenocortical secretion.

Effects of intracerebroventricular and intrahypothalamic cocaine administration on adrenocortical secretion.

The Endocannabinoid System is No Longer the Limiting Factor: Why Policy and Stigma Continue to Delay Cannabinoid-Based Medicine.

Physiologically Based Pharmacokinetic Modeling of Lenvatinib to Support Dosing Optimization in Chinese Population.

Effects of Phosphodiesterase-5 Inhibitors on Mortality and Clinical Outcomes in Advanced Interstitial Lung Disease with Severe Impairment in Gas Exchange: A Systematic Review and Meta-Analysis.

Early Hemodynamic Trajectory Phenotypes and Exploratory Albumin Exposure-Mortality Associations in Septic Shock: A Retrospective Cohort Study.

Issues in Monitoring Oncology Trials.

Benefit-Risk Balance for Medicinal Products: Report Summary from the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII.

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Related Experiment Videos

Milestones in clinical pharmacology. Therapy for hypertension

Related Concept Videos

Related Articles